E7820
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for E7820, covering 2014-12-23 to 2026-06-17. Get the full timeline:
Most recent: Clinical Trial Results: A Study of E7820 in People With Bone Marrow (Myeloid) Cancers [Phase 2]